Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*

E. Papadavid; E. Kapniari; V. Pappa; V. Nikolaou; T. Iliakis; M. Dalamaga; C. Jonak; S. Porkert; S. Engelina; P. Quaglino; P. L. Ortiz-Romero; C. Vico; A. Cozzio; F. Dimitriou; R. Guiron; E. Guenova; E. Hodak; M. Bagot; J. Scarisbrick

doi:10.1111/bjd.20588

Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*

E. Papadavid
, E. Kapniari^*
, V. Pappa
, V. Nikolaou
, T. Iliakis
, M. Dalamaga
, C. Jonak
, S. Porkert
, S. Engelina
, P. Quaglino
, P. L. Ortiz-Romero
, C. Vico
, A. Cozzio
, F. Dimitriou
, R. Guiron
, E. Guenova
, E. Hodak
, M. Bagot
, J. Scarisbrick

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1035-1044
Number of pages	10
Journal	British Journal of Dermatology
Volume	185
Issue number	5
DOIs	https://doi.org/10.1111/bjd.20588
Publication status	Published - Nov 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302 Clinical Medicine

Access to Document

10.1111/bjd.20588

Cite this

Papadavid, E., Kapniari, E., Pappa, V., Nikolaou, V., Iliakis, T., Dalamaga, M., Jonak, C., Porkert, S., Engelina, S., Quaglino, P., Ortiz-Romero, P. L., Vico, C., Cozzio, A., Dimitriou, F., Guiron, R., Guenova, E., Hodak, E., Bagot, M., & Scarisbrick, J. (2021). Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*. British Journal of Dermatology, 185(5), 1035-1044. https://doi.org/10.1111/bjd.20588

@article{d146ff5258754389b5931172dbc971e1,

title = "Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and S{\'e}zary syndrome with variable CD30 positivity*",

author = "E. Papadavid and E. Kapniari and V. Pappa and V. Nikolaou and T. Iliakis and M. Dalamaga and C. Jonak and S. Porkert and S. Engelina and P. Quaglino and Ortiz-Romero, \{P. L.\} and C. Vico and A. Cozzio and F. Dimitriou and R. Guiron and E. Guenova and E. Hodak and M. Bagot and J. Scarisbrick",

note = "Publisher Copyright: {\textcopyright} 2021 British Association of Dermatologists",

year = "2021",

month = nov,

doi = "10.1111/bjd.20588",

language = "English",

volume = "185",

pages = "1035--1044",

journal = "British Journal of Dermatology",

issn = "0007-0963",

number = "5",

}

Papadavid, E, Kapniari, E, Pappa, V, Nikolaou, V, Iliakis, T, Dalamaga, M, Jonak, C, Porkert, S, Engelina, S, Quaglino, P, Ortiz-Romero, PL, Vico, C, Cozzio, A, Dimitriou, F, Guiron, R, Guenova, E, Hodak, E, Bagot, M & Scarisbrick, J 2021, 'Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*', British Journal of Dermatology, vol. 185, no. 5, pp. 1035-1044. https://doi.org/10.1111/bjd.20588

TY - JOUR

T1 - Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*

AU - Papadavid, E.

AU - Kapniari, E.

AU - Pappa, V.

AU - Nikolaou, V.

AU - Iliakis, T.

AU - Dalamaga, M.

AU - Jonak, C.

AU - Porkert, S.

AU - Engelina, S.

AU - Quaglino, P.

AU - Ortiz-Romero, P. L.

AU - Vico, C.

AU - Cozzio, A.

AU - Dimitriou, F.

AU - Guiron, R.

AU - Guenova, E.

AU - Hodak, E.

AU - Bagot, M.

AU - Scarisbrick, J.

PY - 2021/11

Y1 - 2021/11

UR - https://www.scopus.com/pages/publications/85112846157

U2 - 10.1111/bjd.20588

DO - 10.1111/bjd.20588

M3 - Article

C2 - 34137025

AN - SCOPUS:85112846157

SN - 0007-0963

VL - 185

SP - 1035

EP - 1044

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -

Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this